News
Latest Association news, industry events, official statements, and information about ongoing initiatives.
News
Looking Back at One of the Key Moments of the 5th International Pharmaceutical Forum of Uzbekistan 2026
One of the Forum’s key events was the plenary session “Pharmaceutical Market of Uzbekistan 2026–2030: Strategic Balance of Innovation, Localization, and Accessibility.” The Forum was officially opened by Abdulla Azizov, Director of the Agency for the Development of the Medical and Pharmaceutical Industry of the Republic of Uzbekistan. Moderator: • Alexander Panov — Managing Partner, Verba Legal Speakers: • Abdulla Azizov — Agency for the Development of the Medical and Pharmaceutical Industry of the Republic of Uzbekistan • Nurlybek Asylbekov — SK-Pharmacy (Kazakhstan) • Takahiro Hasumi — The World Bank • Tatiana Kubasova — AstraZeneca The session focused on the long-term development of Uzbekistan’s pharmaceutical market through 2030, production localization, investment attraction, expanding access to innovative therapies, and strengthening public-private cooperation.
June 12, 2026
News
The 5th International Pharmaceutical Forum is supported by leading international and regional pharmaceutical companies
The development of a modern pharmaceutical industry depends on effective collaboration between business, professional communities, industry experts, and public institutions. Such partnerships create a foundation for knowledge exchange, innovation, and sustainable market growth. In 2026, the Forum is supported by leading companies from across the pharmaceutical sector. General Partners: • AstraZeneca • GrandPharm • Grandene Pharmaceuticals Main Partner: • Orville Services Forum Partners: • Bayer • Asl Belgisi • Gedeon Richter • Pharma gate • Proxima Research • Verba Legal • Yuriya Pharm • Anabion • Delfield Group • Legalmax With the support of its partners, the Forum will bring together representatives of international pharmaceutical companies, government institutions, industry associations, and the expert community to discuss key challenges and future opportunities for the pharmaceutical sector.
June 1, 2026